Compare Novartis AG (NVS) vs AT&T Inc. (T) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novartis AG vs AT&T Inc. — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while AT&T Inc. trades at $22.3 (market cap $152.52B). The key difference: Novartis AG is the larger of the two by market cap, and AT&T Inc. pays the higher dividend (5.06%). Which is the better fit depends on your goals.
| NVS | T | |
|---|---|---|
Market Cap | $290.25B | $152.52B |
Sector | Health | Media |
52-Week High | $168.62 | $29.62 |
52-Week Low | $113.50 | $20.49 |
Enterprise Value | $330.27B | $297.87B |
Dividend Yield | 3.17% | 5.06% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →About AT&T Inc.
AT&T Inc. is a communications holding company. The Company, through its subsidiaries and affiliates, provides local and long-distance phone service, wireless and data communications, Internet access and messaging, IP-based and satellite television, security services, telecommunications equipment, and directory advertising and publishing.
Read more on T →
